InBody Co.Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.032x

InBody Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, InBody Co.Ltd (041830) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.04 Billion ≈ $6.13 Million USD) by net assets (₩282.02 Billion ≈ $191.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of InBody Co.Ltd (2011–2024)

Cash flow conversion efficiency of InBody Co.Ltd from 2011 to 2024. This chart illustrates how InBody Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 041830 stock price for real-time trading data and today's change.

InBody Co.Ltd Cash Flow Conversion Ratio Explained

InBody Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

InBody Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of InBody Co.Ltd ranked by their cash flow conversion efficiency. Also see how much is InBody Co.Ltd worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Tianjin Yiyi Hygiene Products Co Ltd SHE:001206	0.043x
Ningxia Xiaoming Agriculture & Animal Husbandry Co.Ltd SHE:300967	N/A
Jasmine Telecom Systems Public Company Limited BK:JTS	0.120x
ITAB Shop Concept AB ser. B ST:ITAB	-0.002x
Mekonomen AB ST:MEKO	0.035x
PRA Group Inc NASDAQ:PRAA	-0.010x
Network18 Media & Investments Limited NSE:NETWORK18	-0.016x
Orient Electric Limited NSE:ORIENTELEC	-0.055x

Annual Cash Flow Conversion Efficiency for InBody Co.Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of InBody Co.Ltd from 2011 to 2024. Review InBody Co.Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩273.90 Billion ≈ $185.62 Million	₩28.58 Billion ≈ $19.37 Million	0.104x	-32.63%
2023-12-31	₩249.83 Billion ≈ $169.31 Million	₩38.69 Billion ≈ $26.22 Million	0.155x	+9.58%
2022-12-31	₩215.26 Billion ≈ $145.88 Million	₩30.42 Billion ≈ $20.61 Million	0.141x	-14.45%
2021-12-31	₩183.73 Billion ≈ $124.51 Million	₩30.35 Billion ≈ $20.57 Million	0.165x	-13.02%
2020-12-31	₩150.06 Billion ≈ $101.70 Million	₩28.50 Billion ≈ $19.31 Million	0.190x	+9.60%
2019-12-31	₩139.69 Billion ≈ $94.67 Million	₩24.21 Billion ≈ $16.40 Million	0.173x	+21.74%
2018-12-31	₩124.39 Billion ≈ $84.29 Million	₩17.70 Billion ≈ $12.00 Million	0.142x	-18.41%
2017-12-31	₩106.48 Billion ≈ $72.16 Million	₩18.58 Billion ≈ $12.59 Million	0.174x	-11.71%
2016-12-31	₩92.30 Billion ≈ $62.55 Million	₩18.24 Billion ≈ $12.36 Million	0.198x	+34.91%
2015-12-31	₩76.32 Billion ≈ $51.72 Million	₩11.18 Billion ≈ $7.58 Million	0.146x	-14.89%
2014-12-31	₩59.61 Billion ≈ $40.40 Million	₩10.26 Billion ≈ $6.95 Million	0.172x	+26.86%
2013-12-31	₩51.56 Billion ≈ $34.94 Million	₩6.99 Billion ≈ $4.74 Million	0.136x	+43.70%
2012-12-31	₩46.13 Billion ≈ $31.26 Million	₩4.36 Billion ≈ $2.95 Million	0.094x	-27.61%
2011-12-31	₩42.14 Billion ≈ $28.56 Million	₩5.50 Billion ≈ $3.72 Million	0.130x	--

About InBody Co.Ltd

KQ:041830 Korea Healthcare Equipment & Supplies

Market Cap

$424.41 Million

₩626.27 Billion KRW

Market Cap Rank

#12728 Global

#358 in Korea

Share Price

₩46450.00

Change (1 day)

+0.22%

52-Week Range

₩27050.00 - ₩70800.00

All Time High

₩70800.00